Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-110-7 | CAS number: 3006-82-4
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 978
- Report date:
- 1978
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Principles of method if other than guideline:
- NA
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- tert-butyl 2-ethylperoxyhexanoate
- EC Number:
- 221-110-7
- EC Name:
- tert-butyl 2-ethylperoxyhexanoate
- Cas Number:
- 3006-82-4
- Molecular formula:
- C12H24O3
- IUPAC Name:
- tert-butyl 2-ethylhexaneperoxoate
- Test material form:
- liquid
Constituent 1
Test animals
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
Source: H.A.R.E. Rabbits for Research, Hewitt, New Jersey or Kuiper's Rabbit Ranch, Gary, Indiana
Housing: rabbits were individually housed in hanging wire-mesh cages in temperature and humidity controlled quarters
Conditioning period: 13 days prior to study initiation
Diet: ad libitum
Water: ad libitum
Body weights prior to administration: 2300 to 2804 g
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: back of each rabbit
- % coverage: 20 - 30 % of the body surface
- Type of wrap if used: the application sites were wrapped with gauze bandaging and overwrapped with Saran Wrap. The entire application area was then wrapped with Several layers of 75 mm Elastoplast tape. A collar was also applied.
REMOVAL OF TEST SUBSTANCE
- 24 hours following application, the bandages and collars were removed and the test sites were washed with tepid tap water
- Duration of exposure:
- 24 hours
- Doses:
- 2.5, 5, 10 and 20 g/kg bw
- No. of animals per sex per dose:
- 2 animals per sex per dose (total: 8 animals)
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily
- Necropsy of survivors performed: yes
- Other examinations performed: pharmaceutical signs, mortality, dermal irritation - Statistics:
- 95% Confidence limits
Results and discussion
- Preliminary study:
- No preliminary study
Effect levelsopen allclose all
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 14 142 mg/kg bw
- 95% CL:
- > 7 071 - < 28 284
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 20 000 mg/kg bw
- 95% CL:
- > 10 000 - < 40 000
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 16 818 mg/kg bw
- 95% CL:
- > 11 892 - < 23 784
- Mortality:
- 3 animals (2 females, 1 male) died during the 14 day study period at a dosage level of 20 g.
- Clinical signs:
- other: NA
- Gross pathology:
- NA
- Other findings:
- NA
Any other information on results incl. tables
No remarks
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Eight male and 8 female New Zealand White rabbits were used for this study. The rabbits were divided into 4 groups of 2 male and 2 female rabbits each. The test material was applied once only to the backs of the rabbits at the following dosage levels: 2.5, 5, 10 and 20 g/kg.
Based upon the data obtained, the acute dermal LD50 values and 95% confidence limits (CL) were estimated to be as follows:
male rabbits: 20 g/kg bw with 95%CL of 10 - 40 g/kg bw
female rabbits: 14.14 g/kg bw with 95%CL of 7.07 - 28.28 g/kg bw
Combined male and female rabbits: 16.82 g/kg with 95%CL of 11.89 - 23.78 g/kg - Executive summary:
Tert.-Butylperoxy- 2-ethylhexanoat was tested to eight male and 8 female New Zealand White rabbits were used for this study. The rabbits were divided into 4 groups of 2 male and 2 female rabbits each. The test material was applied once only to the backs of the rabbits at the following dosage levels: 2.5, 5, 10 and 20 g/kg.
Based upon the data obtained, the acute dermal LD50 values and 95% confidence limits (CL) were estimated to be as follows:
male rabbits: 20 g/kg bw with 95%CL of 10 - 40 g/kg bw
female rabbits: 14.14 g/kg bw with 95%CL of 7.07 - 28.28 g/kg bw
Combined male and female rabbits: 16.82 g/kg with 95%CL of 11.89 - 23.78 g/kg
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
